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ABSTRACT
Objectives: This study aimed to describe the prevalence of depressive symptomatology dur-
ing pregnancy when seen in obstetric settings, the extent of treatment in this population, and
specific risk factors associated with mood symptoms in pregnancy.
Methods: A total of 3472 pregnant women age 18 and older were screened while waiting
for their prenatal care visits in 10 obstetrics clinics using a brief (10 minute) screening ques-
tionnaire. This screen measured demographics, tobacco and alcohol (TWEAK problem alco-
hol use screening measure), and depression measures, including the Center for Epidemio-
logical Studies-Depression scale (CES-D), use of antidepressant medications, past history of
depression, and current treatment (i.e., medications, psychotherapy, or counseling) for de-
pression.
Results: Of women screened, 20% (n 5 689) scored above the cutoff score on the CES-D,
and only 13.8% of those women reported receiving any formal treatment for depression. Past
history of depression, poorer overall health, greater alcohol use consequences, smoking, be-
ing unmarried, unemployment, and lower educational attainment were significantly associ-
ated with symptoms of depression during pregnancy.
Conclusions: These data show that a substantial number of pregnant women screened in
obstetrics settings have significant symptoms of depression, and most of them are not being
monitored in treatment during this vulnerable time. This information may be used to justify
and streamline systematic screening for depression in clinical encounters with pregnant 
women as a first step in determining which women may require further treatment for their
mood symptoms. As elevations in depressive symptomatology have been associated with ad-
verse maternal and infant outcomes, further study of the impact of psychiatric treatment in
gravid women is essential.
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INTRODUCTION
ALMOST ONE WOMAN IN FOUR will experience de-pression at some point in her life,1 most 
commonly during the childbearing years.2,3
Women who experience depressive symptoms as-
sociated with childbearing are at greatly increased
risk for future depressions over a 5-year period.4–6
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Self-reported maternal mood symptoms dur-
ing pregnancy have been associated with poor
birth outcomes, including low birth weight, in-
creased risk of premature delivery, and pre-
eclampsia in the mother,7,8 as well as with im-
paired health functioning for the mothers.9
Antenatal mood symptoms often predate post-
partum depression,10 and mood difficulties in
women with infants are associated with poor out-
comes in their children.
Zuckerman et al.11 found a significant associa-
tion between maternal elevated Center for Epi-
demiological Studies-Depression (CES-D) scores
during pregnancy and unconsolability and ex-
cessive crying in their infants. Beginning in the
first few months of life, maternal depressive
symptomatology has been shown to affect re-
sponsiveness to the child,12 behavioral problems,
and delayed cognitive and linguistic develop-
ment.13–15 Many studies exploring postpartum
illness do not differentiate between research di-
agnostic criteria for major depression and minor
depression. There has been ample research in
nongravid women to suggest that minor depres-
sion, not of sufficient duration or severity to meet
the criteria for a major depressive episode, has a
significant and disabling impact.16–19
Although there have been advances in psy-
chopharmacological and psychotherapeutic treat-
ment for depression, many pregnant women do
not seek treatment. A recent study of mental health
issues in pregnancy found that only 1 in 5 women
with a psychiatric disorder in obstetrics settings
had evidence of treatment in the medical charts.20
Another investigation found that a diagnosis of de-
pression was made in only 0.8% of childbearing
women based on a review of diagnostic codes
across a large hospital system.21 Studies to date
have not directly examined the utility of screening
for antenatal depression in obstetrics settings for
optimizing rates of identification and appropriate
treatment. However, the U.S. Preventive Task
Force concluded recently that screening for de-
pression in adults in primary care can improve
rates of detection and treatment when adequate
follow-up mechanisms are in place in the setting.22
At this point, there are no clear guidelines for ap-
propriate treatment of antenatal and postnatal de-
pression. However, Wisner et al.23 have presented
a risk-benefit decision-making model that incor-
porates a number of factors, including the risks
and benefits of medication use and attitudes and
preferences of the patient, her family, and her ob-
stetrician. The antenatal visit may provide an ideal
venue for initial screening and intervention, as (1)
the perinatal period is a high risk time for the emer-
gence of depressive symptoms and (2) most preg-
nant women will seek prenatal care at some point
during their pregnancy.
Identification of risk factors for elevated de-
pression in pregnancy may help to target screen-
ing efforts. Previous studies have found personal
and family history of mood disorder, marital con-
flict, younger age, and limited social support with
greater number of children to be risk factors for
depression in pregnancy.24,25 A recent study also
found scores on a substance abuse screening mea-
sure to be significantly associated with antenatal
depression, as measured by the Edinburgh Post-
natal Depression Scale.26 Other data have shown
a link between depression in pregnancy and sub-
stance abuse, including smoking.27,28 Depression
in pregnancy has been linked to lower educa-
tional attainment, unemployment, and marital
status, particularly in lower-income women.29 A
prior history of depression is perhaps the
strongest predictor of future depression.30 The
risk of postpartum depression in women who
have histories of depression is high, with esti-
mates ranging from 25% to 50%.24
As antenatal depressive symptoms may have
a negative impact on both mother and infant and
may predispose women to the development of
postpartum depression, three research questions
were addressed in this study. First, we examined
the prevalence of elevated depressive sympto-
matology in pregnant women as identified by
screening in obstetrics settings. Second, we ex-
amined rates of reported receipt of formal treat-
ment (i.e., medications, psychotherapy, or coun-
seling) for depression among those who may be
considered at risk for depression. Finally, we ex-
amined demographic and psychosocial risk fac-
tors associated with elevated depressive sympto-
matology during pregnancy in obstetrics settings.
MATERIALS AND METHODS
Procedures
As part of an ongoing intervention project,
pregnant women were screened in obstetrics clin-
ics while waiting for their prenatal care visit. A
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total of 3472 pregnant women were screened in 10
obstetrics clinics in southeastern Michigan. All
pregnant women were approached by research
staff in the waiting area of the clinics and asked to
participate, and 90% of all women approached
agreed to complete the screening survey. Women
who chose not to participate refused further con-
tact with the research assistant after the initial ap-
proach. Therefore, it was not possible to collect in-
formation on their characteristics. Confidentiality
was maintained by the use of randomly chosen
study code numbers, and all procedures were ap-
proved by the University of Michigan Medical
School Institutional Review Board. Screening mea-
sures included demographic information, ratings
of overall health, lifetime and recent depression,
current distress (CES-D), risk drinking (TWEAK),
and use of prescription medications.
Participants
Demographic characteristics of participants are
shown in Table 1. A wide range of ages was sam-
pled (18–46 years, mean 28.6 (SD 6.0). The
racial/ethnic distribution of our sample closely re-
flects that of our screening county.31 Women were
screened in the clinical settings at an average of 25
weeks of gestation (SD 10.4), with a range of 3–41
weeks. Most women were married, and most re-
ported educational attainment beyond high school.
Measures
The screening questionnaire consisted of items
assessing demographic characteristics (age, mar-
ital status, employment status, educational at-
tainment, parity, weeks gestation, racial/ethnic
status), health behaviors during pregnancy (such
as overall physical health rated on a 5-point scale
from poor to excellent), and use of alcohol and
tobacco. Women were asked to indicate whether
they had taken medication for depression in the
past 2 years, whether they were currently taking
the medication, and whether they had discontin-
ued the medication as a result of becoming preg-
nant or during prepregnancy planning. The
screening questionnaire also included the
TWEAK as an alcohol screener.32 The TWEAK
has been found to demonstrate good sensitivity
and specificity in screening for risk drinking in
women and during pregnancy,33 using a cutoff
score of 2. It is a 5-item measure, from which a
total severity score may be derived.
Current depressive symptomatology was mea-
sured by the CES-D. The CES-D is used widely
as a screening instrument to detect depression in
nonclinical populations and has been found to
have adequate sensitivity in identifying a diag-
nosis of major depression based on an interview
using the Structured Interview for the DSM-III-R
in a primary care population of adult men and
women.34 Items on the CES-D cover the previous
7 days and are rated on a 4-point scale. A total
score is derived by summing the ratings across
the 20 items. Good internal consistency (Cron-
bach’s alpha 5 0.84) has been found for the CES-
D in the general population35 and with pregnant
women (0.88–0.91).36 The standard cutoff point of
16 was used to determine elevated distress.37 This
cutoff point has been used as an indicator of clin-
DEPRESSIVE SYMPTOMS IN PREGNANT WOMEN 375
TABLE 1. DEMOGRAPHIC AND HEALTH-RELATED
CHARACTERISTICS OF STUDY SAMPLE (n 5 3472)
Characteristic Result
Maternal age (years) 28.6 6 6.0a0
Parity 0.87 6 1.1a0
Weeks pregnant at screening 25 6 10.4a
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ically significant elevated depressive symptoma-
tology in community samples38 as well as with
pregnant women.36,39
Measures of past history of depression and
treatment for depression were also included in
the screening questionnaire. Past history was
measured using items focusing on depression
that were derived from the Diagnostic Interview
Schedule (DIS-III-R).40 These items included
questions assessing lifetime depression and re-
cent depression (within the last 6 months) by ask-
ing participants if within the specified time frame,
“ . . . you had two weeks or more when nearly
every day you felt sad, blue, or depressed or in
which you lost all interest in things like work?”
The sensitivity of these items as screeners for de-
pression were found to range between 0.83 and
0.94.41 Finally, current treatment for depression
was assessed with two items. Women were asked
to indicate if they were currently receiving coun-
seling, psychotherapy, or medication for depres-
sion or emotional problems (dichotomously
coded, yes/no). A second item asked women to
indicate the number of sessions they have had
with a counselor or therapist for depression in the
last 3 months.
Data analysis plan
Descriptive information on study participants
was examined and is shown in Table 1. We were
also interested in descriptive information on de-
pression-related items, such as rates of past his-
tory of depression and rates of current treatment
for depression among those at risk (as measured
by self-reports of depression in the past 6 months
and by current elevated CES-D). Therefore,
prevalence of this depression-related information
was also examined for our sample.
The primary analyses for this study focused on
demographic and health behavior variables asso-
ciated with elevated depressive symptomatology,
as measured by CES-D. Bivariate logistic regres-
sion was used to examine the factors associated
with elevated depression. Women were divided
into two groups based on their CES-D score, $16
and ,16, and this was used as the outcome vari-
able in the analyses. Independent variables were
selected based on previously studied demo-
graphic and health-related correlates of perinatal
depression. The independent variables were ma-
ternal age, marital status, education, racial/eth-
nic status, employment status, parity, number of
weeks gestation, lifetime history of depression,
self-rated overall health, smoking during preg-
nancy, and alcohol use problems as measured by
TWEAK. Independent variables were entered si-
multaneously in a single equation. This method
allows for examination of the association of each
independent variable to the outcome variable af-
ter controlling for all other variables in the equa-
tion. Thus, the influence of each variable on the
outcome variable is calculated above and beyond
every other variable in the equation.42 Overall
model and individual variable statistics are pre-




Overall, 20.4% (n5 689) of pregnant women
screened showed elevated depressive symptoma-
tology as measured by a CES-D score of $16. Of
these women, 13.8% (n 5 91) reported that they cur-
rently were receiving any kind of formal treatment
for depression (defined as any psychotherapy, med-
ications, or counseling). The majority of women
with elevated CES-D reported receiving no session
with a counselor or therapist in the past 3 months
(85%), and 7% reported less than one session per
month with a counselor or therapist in the past 3
months. Of those who reported depression in the
past 6 months (8.6%, n 5 297) (as measured by 2
weeks or more of feeling sad, blue, depressed or
losing all interest in things such as work), 24.6% re-
ported currently receiving any form of treatment
for depression. Given the high risk of relapse among
those with any prior history of depression, we were
also interested in the rates of elevated depressive
symptomatology among women with a past his-
tory. A total of 958 (28%) women reported a life-
time history of major depression (as measured by
2 weeks or more of feeling sad, blue, depressed or
losing all interest in things such as work). Of those,
42.6% (n5 398) reported current elevated depres-
sive symptomatology (based on CES-D cutoff $16).
Factors associated with elevated 
depressive symptomatology
Bivariate logistic regression analysis was per-
formed using elevated CES-D as the outcome
variable, with the following independent vari-
ables: maternal age, marital status, race/ethnic-
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ity, education (i.e., number of years of school
completed), maternal employment status, num-
ber of weeks gestation, parity, lifetime history of
depression (yes/no), self-rated overall health, al-
cohol use problems as measured by TWEAK, and
number of cigarettes smoked per day during
pregnancy. The overall chi-square for the model
was found to be significant (chi-square 5 559(11),
p 5 0.000). Residuals and goodness-of-fit were
checked in the final model (Hosmer and Leme
show test chi-square p value 5 0.86). There was
no evidence of lack of fit in the final model.
Logistic regression statistics, including stan-
dardized coefficients, p values, and ORs associ-
ated with each study variable, are presented in
Table 2. Holding all other factors constant, 
women who reported a prior history of depres-
sion were 4.9 times more likely to have an ele-
vated CES-D than women who reported no such
history. Women who rated their overall health as
poorer, who had greater alcohol use problems (as
measured by TWEAK), and who smoked more
cigarettes per day while pregnant were signifi-
cantly more likely to have elevated CES-D. (OR 5
1.5, 1.2, and 1.1, respectively). Women with lower
educational attainment, those who were not
working, and those unmarried or without a live-
in partner were also significantly more likely to
have elevated depressive symptomatology (OR 5
0.90, 0.74, and 0.57, respectively). Maternal age,
parity, number of weeks gestation, and race/eth-
nicity were found to be unrelated to CES-D.
DISCUSSION
Our data show that a substantial number (20%)
of pregnant women screened antenatally in obstet-
rics settings reported significant depressive symp-
tomatology. Most (86%) were not receiving any
treatment (defined as medication, psycho-therapy,
or counseling) during this vulnerable time. Routine
monitoring for depression does not occur in most
obstetrics settings, including those used as the study
sites. Thus, although not directly assessed, it is likely
that these women were not being monitored by a
healthcare professional for possible worsening of
symptoms. Almost half of the women in our sam-
ple with a self-reported past history of major de-
pressive disorder (MDD) (42.5%) reported recur-
rence of mood symptoms during the pregnancy.
Although the impact of mood symptoms on the
developing fetoplacental unit has not been fully
elucidated, preliminary human and animal stud-
ies suggest that untreated psychiatric symptoms
may impact the developing fetus and adversely
affect neonatal outcome.7,43–46 Thus, antenatal
screening in this population may identify women
who may be at risk for such adverse pregnancy
outcomes as prematurity and preeclampsia, 
enabling appropriate obstetric surveillance. As
many women who develop postpartum depres-
sion have antecedent symptoms during preg-
nancy, screening for mood symptoms during
pregnancy may also identify women at high risk
for postpartum depression.47
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TABLE 2. STANDARDIZED REGRESSION COEFFICIENTS, STATISTICS, p VALUES, AND ODDS RATIOS FOR
VARIABLES PREDICTING ELEVATED DEPRESSIVE SYMPTOMATOLOGYa AS IN PREGNANT WOMEN
SCREENED IN OBSTETRICS SETTINGS (n 5 2991)b BASED ON BIVARIATE LOGISTIC REGRESSION
Variable B Wald p valuec Odds ratio
Maternal age 20.02 2.6 NS —
Marital status 20.56 15.6 0.00 0.57
Minority 0.10 0.69 NS —
Education 20.10 4.0 0.04 0.90
Employment status 20.30 7.5 0.01 0.74
No. of weeks gestation 0.00 0.06 NS —
Parity 0.06 1.5 NS —
Lifetime depression (yes/no) 1.6 241.5 0.00 4.90
Self-rated health 0.39 40.2 0.00 1.50
TWEAK 0.211 18.9 0.00 1.20
Smoking while pregnant 0.13 8.7 0.00 1.10
aCenter for Epidemiological Studies-Depression Scale cutoff score , 16 or $ 16.
bn is smaller than total sample because of listwise deletion of missing variables included in the logistic regression
analysis.
cSignificance levels based on p , 0.05.
In fact, screening for depression in obstetrics
settings appears to be feasible, as we were able to
obtain surveys on 3472 pregnant women in 10
clinics over a 3-year period. The majority of 
women approached (90%) agreed to complete the
screening survey. Our study demonstrated that
administration and scoring of screening tools can
be done successfully by nonclinical staff (in this
study, undergraduate research assistants).
The efficiency of screening in obstetrics may be
improved by identification of risk factors for de-
pressive symptomatology and depression risk.
We found several factors to be strongly predic-
tive of depressive symptoms during pregnancy.
These include previous episodes of major de-
pressive illness, poor self-rated health, and
greater alcohol use and use of cigarettes while
pregnant. Demographic factors, such as not liv-
ing with a spouse/significant other, not working,
and less education, were also significantly related
to elevated symptoms of depression during preg-
nancy. Other demographic and socioeconomic
factors as well as health behaviors, such as age,
parity, stage of pregnancy, and race, were not cor-
related with pregnancy-related depression. As
has been found in other studies of predictors of
postnatal depression, self-reported prior history
of depression was most strongly related to ele-
vated depressive symptomotology during preg-
nancy.48 Thus, women with a past history of de-
pression should be targeted for more intensive
assessment during early pregnancy. Similarly, as
our data suggest, it may be useful for physicians
or other clinical staff to flag those not working,
those unmarried, those with greater health com-
plaints, and those who use alcohol and cigarettes
as possible markers of elevated depression.
Such women represent a critical subpopulation
who could benefit from more intensive assess-
ment and intervention. More research is needed
on optimal and appropriate treatment for women
with antenatal minor or major depression. In the
meantime, women, their families, and their
physicians should be made aware of current
knowledge on the safety and efficacy of pharma-
cological and psychotherapeutic treatments. For
example, interpersonal psychotherapy has been
found to be efficacious for the treatment of post-
natal depression.49 A risk-benefit model of treat-
ment decision making that considers a variety of
factors related to the well-being of the mother and
infant has been proposed.23
Several limitations should be noted in inter-
preting the results of this study. First, research 
assistants were used to collect screening data,
which raises questions about the generalizability
of implementation of large-scale screening ef-
forts. Women were largely receptive to complet-
ing a brief screening survey while they waited for
their prenatal care visits. However, future stud-
ies should examine the feasibility of implemen-
tation by clinical or clerical staff. Second, our
study used measures of self-report for depression
symptomatology and did not obtain diagnoses of
MDD. Moreover, the study included only a sin-
gle time for assessment of mood symptoms, col-
lecting the self-report at variable times during the
pregnancy (3–41 weeks) and not monitoring the
course of the illness per se. Although distress and
minor depression can be very debilitating and are
associated with adverse pregnancy outcomes, ad-
ditional work on the prevalence of MDD and its
impact during pregnancy must be completed. Al-
though the majority of those at risk reported not
receiving any treatment, it is unclear if all of these
women would necessarily benefit from treat-
ment. We also do not have more specific infor-
mation on any treatment or healthcare related to
depression beyond the use of medications, psy-
chotherapy, or counseling. Although these repre-
sent the treatment options for depression that
have received the most study, there may be other
types of interventions that women use that may
be useful for their symptoms (e.g., religious ad-
visement). Future studies may identify predictors
of response to treatment along the continuum of
depression. The impact of such treatment inter-
ventions on fetal and infant neurodevelopment
must be further explored as well. Data obtained
from this project highlight that depressive symp-
tomatology is common in obstetrics settings. Re-
search and clinical emphasis on appropriately
targeted treatment will likely improve symptoms
and overall functioning of these women and may
help to minimize the adverse consequences of
maternal mood symptoms on pregnancy out-
comes.
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